Company Filing History:
Years Active: 2009-2015
Title: Paul Warrener: Innovator in Photosynthetic Microorganisms
Introduction
Paul Warrener is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of genetically modified photosynthetic microorganisms. With a total of 7 patents to his name, Warrener's work focuses on enhancing the production of lipids and triglycerides through innovative genetic modifications.
Latest Patents
Warrener's latest patents include groundbreaking technologies that utilize modified photosynthetic microorganisms. One of his patents describes genetically modified Cyanobacteria that contain exogenous genes encoding diacylglycerol acyltransferase, phosphatidate phosphatase, and acetyl-CoA carboxylase. These microorganisms are capable of producing increased amounts of fatty acids and synthesizing triglycerides. Another patent focuses on genetically modified Cyanobacteria that can produce an increased amount of lipids and fatty acids by incorporating genes for phospholipase and thioesterase. This innovation also includes microorganisms with mutations in glycogen biosynthesis pathways, allowing them to accumulate reduced amounts of glycogen under nitrogen-limited conditions.
Career Highlights
Throughout his career, Paul Warrener has worked with prominent companies in the biotechnology sector. He has been associated with Matrix Genetics, LLC and Novartis Vaccines & Diagnostics GmbH. His work in these organizations has contributed to advancements in genetic engineering and microbial biotechnology.
Collaborations
Warrener has collaborated with notable professionals in his field, including James M. Roberts and Fred Cross. These collaborations have further enriched his research and development efforts in the biotechnology domain.
Conclusion
Paul Warrener's innovative work in the field of genetically modified microorganisms has the potential to revolutionize lipid production. His contributions through patents and collaborations highlight his role as a leading inventor in biotechnology.